Corvus Pharmaceuticals Director Buys: What It Signals
When a company director buys a sizable stake, investors take notice. This article breaks down the meaning behind the ...
Biotech Investing
On this Biotech Investing tag page, 5 recent articles cover innovative biotech stocks, Agios moves, Arcellx updates, Cogent Biosciences and more, giving you quick, actionable finance insights.
109 articles
Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
What Does Adaptive Biotech Insider Sale Signal for Investors
Insider sales in biotech can spark questions about a company’s future. This guide breaks down what to watch, how to r...
Aethlon (AEMD) 2026 Earnings: What Investors Should Watch
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
Kyverna Therapeutics vs Vertex Pharmaceuticals: 2026 Buy Guide
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Crispr Therapeutics Stock Absurdly Cheap—437% Upside Explained
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...
Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
CytomX (CTMX) 2025 Earnings Outlook for Investors Worldwide
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Inmune (INMB) 2025 Earnings Outlook for Investors
Biotech investing hinges on milestones and discipline. This article breaks down inmune (INMB) 2025 earnings, what the...
Related Topics
#Stock Analysis (25)
#Earnings Analysis (22)
#Portfolio Management (15)
#Portfolio Strategy (13)
#Stock Market (12)
#Investing (10)
#Insider Trading (10)
#risk-management (8)
#Hedge Funds (7)
#Earnings (5)
#Healthcare Stocks (5)
#SEC Filings (5)
#Investment Strategy (4)
#Stock Market News (4)
#Small-Cap Stocks (4)